Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

June 30, 2026

Conditions

Irritable Bowel Syndrome With DiarrheaFecal Microbiota TransplantationMental Health Issue

Interventions

PROCEDURE

Fecal Microbiota Transplantation

Oral Fecal Microbiota Transplantation Capsule

PROCEDURE

Placebo

Oral Placebo Capsule

Trial Locations (1)

Shenzhen Hospital of Southern Medical University, Shenzhen

All Listed Sponsors

lead

Shenzhen Hospital of Southern Medical University

OTHER

NCT06297421 - Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults | Biotech Hunter | Biotech Hunter